InvestorsHub Logo
icon url

PennyWorld

08/07/23 6:28 AM

#36098 RE: medicinecat #36093

I've always put RVVTF and RLFTF in the same category. Both are foreign entities (foreign to the FDA), both are tiny bitechs, neither has revenues, and both claimed to have a near-cure for COVID. So now here they are. Both are hovering between 2 and 3 cents a share. One recently had a devastating R/S, and I predict the other will have one on the near horizon.

MF is the Shroom King with misplaced priorities, and that is brought this company down. JMHO.